We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRCH icon
3851
Porch Group
PRCH
$1.79B
$21K ﹤0.01%
+1,110
New +$18.3K
RGCO icon
3852
RGC Resources
RGCO
$222M
$21K ﹤0.01%
824
+244
+42% +$5.52K
SLNO
3853
DELISTED
Soleno Therapeutics
SLNO
$21K ﹤0.01%
1,226
-3,559
-74% -$60.1K
STM icon
3854
STMicroelectronics
STM
$49.1B
$21K ﹤0.01%
578
+577
+57,700% +$21.6K
SYRE icon
3855
Spyre Therapeutics
SYRE
$9.06B
$21K ﹤0.01%
121
+15
+14% +$2.73K
TDW icon
3856
Tidewater
TDW
$4.54B
$21K ﹤0.01%
1,734
-6,882
-80% -$91.4K
TSHA icon
3857
Taysha Gene Therapies
TSHA
$1.92B
$21K ﹤0.01%
976
+350
+56% +$8.07K
ULCC icon
3858
Frontier Group Holdings
ULCC
$1.59B
$21K ﹤0.01%
+1,241
New +$24.5K
UONEK icon
3859
Urban One Class D
UONEK
$23.7M
$21K ﹤0.01%
+408
New +$14.3K
AIOT
3860
PowerFleet Inc
AIOT
$381M
$21K ﹤0.01%
2,973
+769
+35% +$5.61K
TCS
3861
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$21K ﹤0.01%
107
-188
-64% -$39.1K
SRT
3862
DELISTED
Startek Inc.
SRT
$21K ﹤0.01%
2,935
+331
+13% +$2.44K
NMRD
3863
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$21K ﹤0.01%
2,035
-86
-4% -$821
ELOX
3864
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$21K ﹤0.01%
265
+183
+223% +$15.3K
LFC
3865
DELISTED
China Life Insurance Company Ltd.
LFC
$21K ﹤0.01%
+2,126
New +$21.8K
ODT
3866
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$21K ﹤0.01%
5,961
+1,040
+21% +$3.57K
CNBKA
3867
DELISTED
Century Bancorp Inc/Mass
CNBKA
$21K ﹤0.01%
186
-172
-48% -$19.4K
AIM
3868
AIM ImmunoTech
AIM
$7.06M
$21K ﹤0.01%
+97
New +$20.8K
AGQ icon
3869
ProShares Ultra Silver
AGQ
$1.43B
$20K ﹤0.01%
437
-2,485
-85% -$121K
ATLC icon
3870
Atlanticus Holdings
ATLC
$1.42B
$20K ﹤0.01%
515
-694
-57% -$24.3K
BCAB icon
3871
BioAtla
BCAB
$5.81M
$20K ﹤0.01%
10
-20
-67% -$45.2K
BG icon
3872
Bunge Global
BG
$21.4B
$20K ﹤0.01%
251
-15,690
-98% -$1.32M
CGEM icon
3873
Cullinan Oncology
CGEM
$1.26B
$20K ﹤0.01%
765
-55
-7% -$1.69K
CLFD icon
3874
Clearfield
CLFD
$400M
$20K ﹤0.01%
535
-1,575
-75% -$55.9K
CRVS icon
3875
Corvus Pharmaceuticals
CRVS
$1.24B
$20K ﹤0.01%
7,654
-35,132
-82% -$96.7K
153 154
155
156 157

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.